Summary of Previously Finalized and Newly Finalized Hospital OQR Program Measure Set for CY 2026 to CY 2031 Payment Determinations Table 138 summarizes the previously finalized and newly finalized Hospital OQR Program measure set for the CY 2026 to CY 2031 payment determinations, which removes the HCHE, Screening for SDOH, Screen Positive Rate for SDOH, and COVID-19 Vaccination Coverage Among HCP measures as discussed in section XIV.C
Diagnosis and treatment of B12 deficiency often proves to be a very difficult challenge for the patient but in some areas a diagnosis of PA (a positive IFAB test) can represent a golden ticket to treatment, leaving others with identical symptoms, but no confirmed diagnosis of PA, without any treatment at all
Sarkaki A, et al
Like other polyphenols, anthocyanins that are consumed through diet are metabolized by the microbiome and the host to create active metabolites that have anti-inflammatory properties, improve vascular outcomes, reduce the risk of myocardial infarction in both men and women, and have additional positive effects on cardiovascular risk factors (583, 584)
No side effects or injection site reactions